Recruiting
Study of personalized treatment using drug combination therapy for young women with early stage hormone receptor-positive breast cancer based on gene expression testing
Registered drugNo placebo
Study of personalized treatment using drug combination therapy for young women with early stage hormone receptor-positive breast cancer based on gene expression testing
Registered drugNo placebo
- Disease:Hormone receptor positive HER2 negative breast cancer
- Substances:AnastrozoleCyclophosphamide+10
Countries:
Ireland
Ireland- Participants:18–64 years
- Substances:Anastrozole
- Sponsor:Unicancer
